SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!
+1 786 238 2170

Global Stem Cells GroupGlobal Stem Cells Group

  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Press Releases
  • Blog
CONTACT
  • Home
  • Corporate News / Blog
  • Our Friend MSCs (Mesenchymal Stem Cells)—Bringing New Life to Old Bones
May 21, 2025

Our Friend MSCs (Mesenchymal Stem Cells)—Bringing New Life to Old Bones

Thursday, March 24, 2016 / Published in Corporate News / Blog

Our Friend MSCs (Mesenchymal Stem Cells)—Bringing New Life to Old Bones

MSCs, Osteoporosis, Mesenchymal stem cells

Understanding MSCs and Their Role in Osteoporosis Treatment

Researchers from the University of Toronto and The Ottawa Hospital have explored the potential of mesenchymal stem cells (MSCs) in treating osteoporosis. MSCs are versatile stromal cells capable of differentiating into bone cells (osteoblasts), cartilage cells (chondrocytes), muscle cells (myocytes), and fat cells (adipocytes).

Research Insights: MSCs Reverse Osteoporosis in Mice

Our Friend MSCs (Mesenchymal Stem Cells)—Bringing New Life to  Old Bones

In a groundbreaking study published in Stem Cells Translational Medicine, researchers injected healthy MSCs into mice with osteoporosis. Over six months—a significant period in a mouse’s lifespan—the damaged, brittle bones of the mice were replaced with healthy bone tissue. This restoration underscores the regenerative potential of MSCs in treating bone disorders.

Clinical Applications and Future Directions

This discovery raises hopes for new osteoporosis treatments in humans. Early trials involving elderly patients in the US have shown promising results, with ongoing studies assessing improvements in bone health through biological markers in blood samples.

The Global Impact of Osteoporosis

Our Friend MSCs (Mesenchymal Stem Cells)—Bringing New Life to  Old Bones

Globally, over 200 million people suffer from postmenopausal or age-related osteoporosis, leading to approximately 8.9 million bone fractures annually. Current treatments, like Teriparatide, offer temporary relief, highlighting the urgent need for more effective, long-term solutions.

Key Researchers and Publications

Dr. William Stanford, senior scientist at The Ottawa Hospital Research Institute and professor at the University of Ottawa, led the study linking MSC defects to age-related osteoporosis in mice. Co-author Dr. John E. Davies, professor at the University of Toronto, contributed to the study’s publication in Stem Cells Translational Medicine on March 17, 2016.

Tagged under: blog, menenchymal stem cells, MSCs, osteoporosis, stem cells

What you can read next

The different types of stem cells and their current uses
PROTEINS PRODUCED BY STEM CELLS, USED IN BONE REGENERATION
STANFORD RESEARCHERS ISOLATE SKELETAL STEM CELLS THAT GIVE RISE TO BONES AND CARTILAGE

Leave a Reply

Your email address will not be published. Required fields are marked *

Send Us a Message

Contact Home GSCG website

Name(Required)
Email(Required)
Please let us know what's on your mind. Have a question for us? Ask away.
  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Testimonials
  • Press Releases
  • Blog

Copyright © 2024 Stem Cells Group | All Rights Reserved

CONTACT US

Datran Center 9100 S Dadeland Boulevard, Suite 1500. Miami Fl. 33156 United States

305-560-5337

info@stemcellsgroup.com

STAY CONNECTED

Get the latest news, updates, and promotions. Follow us on our social networks.

Certification issued by ISSCA

  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Testimonials
  • Press Releases
  • Blog

Copyright © 2024 Stem Cells Group | All Rights Reserved

CONTACT US

Datran Center 9100 S Dadeland Boulevard, Suite 1500. Miami Fl. 33156 United States

305-560-5337

info@stemcellsgroup.com

STAY CONNECTED

Get the latest news, updates, and promotions. Follow us on our social networks.

Certification issued by ISSCA

TOP